Recent advances permit the detection of activated piatelets using specific monoclonal antibodies and flow cytometry. Nevertheless, there are few reports in which activated platelets have been studied over a period of time in patients at risk for thrombosis. Our patient S.D. has essential thrombocyth
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia
β Scribed by M. Bazzan; G. Tamponi; P. Schinco; A. Vaccarino; C. Foli; G. Gallone; A. Pileri
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 61 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We describe a case of essential thrombocythemia in a 34-year-old male who presented with acute anterior wall myocardial infarction and a platelet count of 2,100,000/mm 3 . Primary percutaneous coronary angioplasty and stenting were performed. Postangioplasty course was complicated by stent thrombosi
## Abstract ## BACKGROUND: Advanced age and a history of thrombosis were wellβestablished risk factors for thrombosis in essential thrombocythemia (ET) and polycythemia vera (PV); cytoreductive therapy was indicated in their presence. Recent studies have suggested leukocytosis as an additional ris